E72.81
BillableDisorders of gamma aminobutyric acid metabolism
HCC Category Mapping
What This Code Means
A rare metabolic disorder affecting the body's ability to produce or use GABA, a neurotransmitter important for calming nerve activity in the brain.
Coding Tips
- •Document any neurological symptoms such as seizures, developmental delay, or movement disorders
- •Note whether this is a deficiency or excess of GABA metabolism
Clinical Significance
Disorders of gamma-aminobutyric acid (GABA) metabolism are rare neurometabolic conditions that disrupt the brain's primary inhibitory neurotransmitter system. These include succinic semialdehyde dehydrogenase deficiency and GABA-transaminase deficiency, causing seizures, developmental delay, and movement disorders. These patients require specialized neurological care and metabolic management, making accurate coding critical for risk adjustment.
Documentation Requirements
- ✓Specific GABA metabolism disorder identified (e.g., succinic semialdehyde dehydrogenase deficiency, GABA-transaminase deficiency)
- ✓Laboratory confirmation such as elevated 4-hydroxybutyric acid in urine or abnormal GABA levels in cerebrospinal fluid
- ✓Genetic testing results if available
- ✓Documentation of neurological manifestations including seizures, ataxia, or behavioral disturbances
- ✓Current treatment plan and medications for symptom management